Keros ends mid-stage trial for lead asset after adverse events Keros ends mid-stage trial for lead asset after adverse events Post ContentkrosRead More You might also be interested in reading Layer-1 Platform Radix Cuts Workforce by 15%. January 15, 2025 In Mainstream ← Previous post Next post →